Return to Trial Database

BTCRC-GI15-067

A phase II study to evaluate the efficacy of liposomal irinotecan in combination with oxaliplatin, leucovorin, and 5-fluorouracil for patients with locally advanced pancreatic carcinoma: Big Ten Cancer Research Consortium BTCRC-GI15-067

Status

Enrollment Closed

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial BTCRC-GI15-067 being conducted in.

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Penn State Cancer Institute

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Rutgers Cancer Institute of New Jersey